(Stock image generated with AI.)
  • CIBC reported Q3 2025 net income of C$2.1 billion, up 17% year-over-year, with revenue rising 10% to C$7.25 billion.
  • Capital Markets earnings surged 87% to C$540 million, while Canadian and U.S. banking units also posted double-digit growth.
  • Provisions for credit losses increased to C$559 million but remained below analyst forecasts, supporting stronger-than-expected adjusted EPS of C$2.16.

Canadian Imperial Bank of Commerce (CIBC—TSX: CM, NYSE: CM) delivered a sharp beat in its third quarter, posting revenue of C$7.25 billion (a 10% gain YoY) and reported net income of C$2.1 billion, up 17% from Q3 2024.

The bank’s performance was driven by robust momentum across all key segments, especially capital markets, and fueled by disciplined cost control and strategic investments, according to its latest earnings report.

This content has been prepared as part of a partnership with CIBC and is intended for informational purposes only.

“In the third quarter of 2025, we delivered strong financial performance by continuing to execute on our client-focused strategy, delivering further momentum, high-quality diversified earnings and top-tier returns for our shareholders,” said Victor G. Dodig, CIBC’s President and CEO.

Balanced growth across core segments

CIBC’s Canadian Personal & Business Banking posted net income of C$812 million, a 17% YoY increase, thanks to stronger net interest margins and volume growth, despite elevated provisions and tech-related costs.

The Canadian Commercial Banking & Wealth Management arm delivered record earnings of C$598 million (up 19%) powered by higher volumes and market-led gains.

In the U.S., Commercial Banking & Wealth Management recorded US$186 million (C$254 million) in net income, a 17% YoY uptick, lifted by revenue growth and lower credit-loss provisions.

Capital markets deliver standout gain

The standout star was Capital Markets, which rose with net income of C$540 million, up 87% year-over-year, reflecting surging trading volumes and heightened client activity.

The bank posted adjusted pre-provision, pre-tax earnings of about C$3.29 billion, reflecting 12% YoY growth, while the efficiency ratio improved by ~100 basis points to around 54.8%, signaling stronger cost control. Return on equity remained solid at 14.2%.

Total provisions for credit losses came in at C$559 million, up C$76 million from a year prior, yet still below the average estimate of C$575.7 million.

CIBC’s Q3 results outperformed analyst expectations across the board. The bank’s adjusted EPS of C$2.16 beats the forecast of around C$2, buoyed by strength in capital markets and disciplined expense control.

With credit conditions improving and trade anxieties easing, trading volumes have remained elevated — boding well for continued loan demand and fee income growth. All told, CIBC enters Q4 with strong fundamentals and renewed investor confidence.

Join the discussion: Find out what investors are saying about CIBC on the Canadian Imperial Bank of Commerce Bullboard and check out Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.


More From The Market Online

@ the Bell: TSX hits new record high, only to close lower

Canada’s top stock index came out of the gate hot on Friday to close out the...

@ the Bell: Oracle’s earnings miss sparks tech selloff

Canada’s top stock index rallied on Thursday despite renewed concerns over inflated technology valuations—sparked by Oracle’s...

Market Open: Disney Pops on AI Deal, Broadcom Slides on Backlog Concerns | Dec 12

TSX rises 0.54%, Nasdaq falls 1.10%, gold hits two-month high, oil and Bitcoin drop. Disney gains on AI deal while Broadcom slides on backlog…
Cannabis leaves with Stock Talk and Cannabis Report labels

StockTalk | Cannabis Report: New stores, new shipments, new vapes

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks